User profiles for Stephen R. Bowen
 | Stephen R BowenProfessor, University of Washington Verified email at uw.edu Cited by 1950 |
Quantitative radiomics: impact of stochastic effects on textural feature analysis implies the need for standards
Image heterogeneity metrics such as textural features are an active area of research for
evaluating clinical outcomes with positron emission tomography (PET) imaging and other …
evaluating clinical outcomes with positron emission tomography (PET) imaging and other …
Dosimetric evaluation of a commercial proton spot scanning Monte-Carlo dose algorithm: comparisons against measurements and simulations
RaySearch Americas Inc.(NY) has introduced a commercial Monte Carlo dose algorithm (RS-MC)
for routine clinical use in proton spot scanning. In this report, we provide a validation of …
for routine clinical use in proton spot scanning. In this report, we provide a validation of …
Tumor radiomic heterogeneity: Multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy
Background Robust approaches to quantify tumor heterogeneity are needed to provide
early decision support for precise individualized therapy. Purpose To conduct a technical …
early decision support for precise individualized therapy. Purpose To conduct a technical …
Artificial intelligence (AI) and machine learning (ML) in precision oncology: a review on enhancing discoverability through multiomics integration
Multiomics data including imaging radiomics and various types of molecular biomarkers
have been increasingly investigated for better diagnosis and therapy in the era of precision …
have been increasingly investigated for better diagnosis and therapy in the era of precision …
Clinical commissioning of a pencil beam scanning treatment planning system for proton therapy
Purpose: In this report, we present the commissioning and validation results for a commercial
proton pencil beam scanning RayStation treatment planning system. Materials and …
proton pencil beam scanning RayStation treatment planning system. Materials and …
[HTML][HTML] Advanced proton beam dosimetry part I: review and performance evaluation of dose calculation algorithms
The accuracy of dose calculation is vital to the quality of care for patients undergoing proton
beam therapy (PBT). Currently, the dose calculation algorithms available in commercial …
beam therapy (PBT). Currently, the dose calculation algorithms available in commercial …
Functional lung avoidance and response‐adaptive escalation (FLARE) RT: multimodality plan dosimetry of a precision radiation oncology strategy
…, T Wong, HJ Vesselle, R Rengan, SR Bowen - Medical …, 2017 - Wiley Online Library
Purpose Nonsmall cell lung cancer ( NSCLC ) patient radiation therapy ( RT ) is planned
without consideration of spatial heterogeneity in lung function or tumor response. We assessed …
without consideration of spatial heterogeneity in lung function or tumor response. We assessed …
Intensity-modulated x-ray (IMXT) versus proton (IMPT) therapy for theragnostic hypoxia-based dose painting
In this work the abilities of intensity-modulated x-ray therapy (IMXT) and intensity-modulated
proton therapy (IMPT) to deliver boosts based on theragnostic imaging were assessed. …
proton therapy (IMPT) to deliver boosts based on theragnostic imaging were assessed. …
[HTML][HTML] Multitask learning radiomics on longitudinal imaging to predict survival outcomes following risk-adaptive chemoradiation for non-small cell lung cancer
Simple Summary Personalized cancer treatment strategies, including risk-adaptive
chemoradiation therapy based on medical imaging, seek to improve outcomes of patients with …
chemoradiation therapy based on medical imaging, seek to improve outcomes of patients with …
[HTML][HTML] Advanced proton beam dosimetry part II: Monte Carlo vs. pencil beam-based planning for lung cancer
Background Proton pencil beam (PB) dose calculation algorithms have limited accuracy
within heterogeneous tissues of lung cancer patients, which may be addressed by modern …
within heterogeneous tissues of lung cancer patients, which may be addressed by modern …
